| Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole CL Birmingham, AC Smith, MA Bakowski, T Yoshimori, JH Brumell Journal of Biological Chemistry 281 (16), 11374-11383, 2006 | 715 | 2006 |
| The functional landscape of mouse gene expression W Zhang, QD Morris, R Chang, O Shai, MA Bakowski, N Mitsakakis, ... Journal of biology 3, 1-22, 2004 | 371 | 2004 |
| Microsporidian genome analysis reveals evolutionary strategies for obligate intracellular growth CA Cuomo, CA Desjardins, MA Bakowski, J Goldberg, AT Ma, JJ Becnel, ... Genome research 22 (12), 2478-2488, 2012 | 287 | 2012 |
| Salmonella‐Containing Vacuoles: Directing Traffic and Nesting to Grow MA Bakowski, V Braun, JH Brumell Traffic 9 (12), 2022-2031, 2008 | 249 | 2008 |
| Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 B Boras, RM Jones, BJ Anson, D Arenson, L Aschenbrenner, ... Nature communications 12 (1), 6055, 2021 | 199 | 2021 |
| The phosphoinositide phosphatase SopB manipulates membrane surface charge and trafficking of the Salmonella-containing vacuole MA Bakowski, V Braun, GY Lam, T Yeung, W Do Heo, T Meyer, BB Finlay, ... Cell host & microbe 7 (6), 453-462, 2010 | 190 | 2010 |
| Ubiquitin-Mediated Response to Microsporidia and Virus Infection in C. elegans MA Bakowski, CA Desjardins, MG Smelkinson, TA Dunbar, ... PLoS pathogens 10 (6), e1004200, 2014 | 185 | 2014 |
| Alternative splicing of conserved exons is frequently species-specific in human and mouse Q Pan, MA Bakowski, Q Morris, W Zhang, BJ Frey, TR Hughes, ... Trends in Genetics 21 (2), 73-77, 2005 | 183 | 2005 |
| Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo E Rosonina, JYY Ip, JA Calarco, MA Bakowski, A Emili, S McCracken, ... Molecular and cellular biology, 2005 | 157 | 2005 |
| A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum A Roth, SP Maher, AJ Conway, R Ubalee, V Chaumeau, C Andolina, ... Nature communications 9 (1), 1837, 2018 | 150 | 2018 |
| Discovery of a novel inhibitor of coronavirus 3CL protease for the potential treatment of COVID-19 B Boras, RM Jones, BJ Anson, D Arenson, L Aschenbrenner, ... BioRxiv, 2020.09. 12.293498, 2020 | 113 | 2020 |
| SopD acts cooperatively with SopB during Salmonella enterica serovar Typhimurium invasion MA Bakowski, JT Cirulis, NF Brown, BB Finlay, JH Brumell Cellular microbiology 9 (12), 2839-2855, 2007 | 108 | 2007 |
| Drug repurposing screens identify chemical entities for the development of COVID-19 interventions MA Bakowski, N Beutler, KC Wolff, MG Kirkpatrick, E Chen, TTH Nguyen, ... Nature communications 12 (1), 3309, 2021 | 96 | 2021 |
| Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication G Garcia, A Sharma, A Ramaiah, C Sen, A Purkayastha, DB Kohn, ... Cell reports 35 (1), 2021 | 80 | 2021 |
| Transcriptional activators control splicing and 3′-end cleavage levels E Rosonina, MA Bakowski, S McCracken, BJ Blencowe Journal of Biological Chemistry 278 (44), 43034-43040, 2003 | 77 | 2003 |
| Role for Myosin II in Regulating Positioning of Salmonella-Containing Vacuoles and Intracellular Replication JA Wasylnka, MA Bakowski, J Szeto, MB Ohlson, WS Trimble, SI Miller, ... Infection and immunity 76 (6), 2722-2735, 2008 | 66 | 2008 |
| Salmonella exploits Arl8B‐directed kinesin activity to promote endosome tubulation and cell‐to‐cell transfer NA Kaniuk, V Canadien, RD Bagshaw, M Bakowski, V Braun, M Landekic, ... Cellular microbiology 13 (11), 1812-1823, 2011 | 54 | 2011 |
| A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii B Luna, V Trebosc, B Lee, M Bakowski, A Ulhaq, J Yan, P Lu, J Cheng, ... Nature microbiology 5 (9), 1134-1143, 2020 | 50 | 2020 |
| Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections MA Bakowski, RK Shiroodi, R Liu, J Olejniczak, B Yang, K Gagaring, ... Science translational medicine 11 (491), eaav3523, 2019 | 42 | 2019 |
| Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis RT Jacobs, CS Lunde, YR Freund, V Hernandez, X Li, Y Xia, DS Carter, ... Journal of medicinal chemistry 62 (5), 2521-2540, 2019 | 42 | 2019 |
